Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

carbamazepine) extended-release capsules

DAYTRANA(TM) (methylphenidate transdermal system)

ELAPRASE(R) (idursulfase)

FOSRENOL(R) (lanthanum carbonate)

INTUNIV(TM) (guanfacine) extended release

LIALDA(TM) (mesalamine)

MEZAVANT(R) (mesalazine)

REMINYL(R) (galantamine hydrobromide) (UK and Republic of Ireland)

REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of Ireland)

REPLAGAL(R) (agalsidase alfa)

VYVANSE(TM) (lisdexamfetamine dimesylate)

XAGRID(R) (anagrelide hydrochloride)

The following are trademarks of third parties referred to in this press release:

3TC (lamivudine) (trademarks of GlaxoSmithKline (GSK))

AMIGAL (migalastat hydrochloride) (trademark of Amicus)

COMBIVIR (lamivudine) (trademark of GSK)

DYNEPO (epoetin delta) (trademark of Sanofi Aventis)

EPIVIR (lamivudine) (trademark of GSK)

EPZICOM (lamivudine) (trademark of GSK)

JUVISTA (trademark of Renovo)

PENTASA (mesalamine) (trademark of Ferring)

PLICERA (isofagomine tartrate) (trademark of Amicus)

RAZADYNE (galantamine) (trademark of Johnson & Johnson)

RAZADYNE ER (galantamine) (trademark of Johnson & Johnson)

REMINYL (galantamine) (trademark of Johnson & Johnson, excluding UK and

Republic of Ireland)

REMINYL XL (galantamine) (trademark of Johnson & Johnson, excluding UK

and Republic of Ireland)

SOLARAZE (diclofenac sodium (3%w/w)) (trademark of Almirall)

VANIQA (eflornithine hydrochloride) (trademark of Almirall)

ZEFFIX (lamivudine) (trademark of GSK)

Overview of US GAAP Financial Results

1. Introduction

Summary of 2007 Revenues from continuing operations for the year to December 31, 2007 increased by 36% to $2,436.3 million (2006: $1,796.5 million).

Operating loss for the year to December 31, 2007 was $1,379.1 million (2006: income of $283.2 million). The loss in 2007 primarily ar
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Today, at the American ... , James McGough , M.D., ... the Semel Institute for Neuroscience and Human Behavior and ... at the University of California Los Angeles (UCLA), and ... Adolescent Psychopharmacology and ADHD at UCLA, presented the results ...
(Date:5/20/2013)... -- Dr. Gerald Zon , noted scientist ... a new blog in conjunction with TriLink BioTechnologies. The ... on what,s trending in the field of nucleic acids. ... of research presented at conferences and meetings, reviews of ... (PhD Princeton University 1971) developed automated synthesis of DNA ...
(Date:5/20/2013)... York, NY (PRWEB) May 20, 2013 With ... Cleaning Products said that although bed bugs need to be ... process will not compromise a person's health. And so to ... guide how to get rid of bed bugs ... its non-pesticide bed bug spray it called Bed Bug Bully. ...
(Date:5/20/2013)... CHAPEL HILL, N.C. , May 20, 2013 ... pharmaceutical company focused on developing differentiated antibiotics to ... bacterial infections, today announced that it presented data ... 2013) in Philadelphia demonstrating ... versus levofloxacin in Cempra,s prior Phase 2 clinical ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... , , SAN ... today that their Chief Executive Officer, William P. Spencer and Chief ... 2009 RedChip New York Equities Conference being held in New York ... is scheduled for 2:05 p.m. Eastern time on Wednesday, September 30, ...
... ... ... iCardiac Technologies, Inc., a leader in advanced cardiac core lab services and QT analysis, ... III cardiac safety study. iCardiac will provide end-to-end study management, site logistics and ...
... Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology ... services to food, supplement, biotechnology and pharmaceutical companies, today announced that ... 2009, at 9:00 a.m. Eastern time, at the Bethesda Marriott Suites, ... The items of business are: , , , ...
Cached Biology Technology:Imagenetix, Inc. to Present at the 2009 RedChip New York Equities Conference 2Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac 2Spherix Incorporated Announces Annual Shareholders Meeting Date 2Spherix Incorporated Announces Annual Shareholders Meeting Date 3
(Date:5/20/2013)... known as the lungs of the planet, inhales carbon dioxide ... air to grow parts that eventually fall to the ground ... rainfall. , Until recently people believed much of the ... up deep in the ocean. University of Washington research showed ... dioxide though left open the question of how that ...
(Date:5/20/2013)... Geology articles posted online ahead of print ... swath of geoscience subdisciplines, including minerals exploration, archaeology, ... studied include Siberia; the Sumatran subduction margin; the ... Mars; and the Southeastern U.S. Atlantic Margin. Brief ... plate tectonics;, 2. The clear fingerprint of ice ...
(Date:5/18/2013)... 18, 2013) Research presented today at Digestive Disease ... with findings about the impact of coffee on autoimmune ... While coffee consumption recently has been associated with reduced ... a few more cups of java each month also ... disease. Researchers at the Mayo Clinic, Rochester, MN, linked ...
Breaking Biology News(10 mins):Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11Coffee consumption associated with reduced risk of autoimmune liver disease 2
... 14, 2010) -- Driven by rapid global industrialization, finite ... alternative energy options, meeting the world,s energy challenge may ... in the ubiquitous industrial invention: the factory. ... (CAMM) -- the only center of its kind in ...
... University have received a 2-year, $5.3 million grant from ... warfighters in the event of exposure to infectious diseases ... colleagues at the Biodesign Institute have taken on a ... that can protect soldiers against an unknown pathogenand do ...
... 13 Developing renewable energy sources has never been ... potential in this field. They convert direct sunlight into ... is constantly advancing, developing technologies that can convert power ... breakthroughs in this area, the editors of Energy Express, ...
Cached Biology News:ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases 2Energy Express focus issue: Thin-film photovoltaic materials and devices 2Energy Express focus issue: Thin-film photovoltaic materials and devices 3
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... System brings together two mature, well-understood ... capture surfaces. This combination produces a ... the detection of molecular binding events ... , Protein-specific capture molecules are immobilized ...
... a comprehensive experiment based analysis package designed ... yet sophisticated and powerful functionality., Image acquisition ... cameras for easy image capture. Sequential ... Video Playback Saturation Warning ...
Biology Products: